Clinical trials: Endoscopic Retrograde Cholangiopancreatography
- Condition Endoscopic Retrograde Cholangiopancreatography
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Endoscopic Retrograde Cholangiopancreatography
Global Prospective Case Series Using a Single-Use Duodenoscope
Confirm procedural performance of the ExaltTM Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures
- Trial name
- NCT04103749
- Testing
- Exalt Model D Single-Use Duodenoscope
- Where
- 22 sites in United States, Australia and 9 more
- Volunteers
- 551 people
- Sponsor
- Boston Scientific Corporation
Cholangiopancreatography, Endoscopic Retrograde
A Clinical Study With the Medical Device PowerSpiral for Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
The objective of the SAMISEN study phase B is to assess the performance and safety of diagnostic and therapeutic procedures with the Olympus Motorized Spiral Enteroscope (PowerSpiral) in subjects with surgically altered…
- Trial name
- SAMISEN-B (NCT05129449)
- Testing
- Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
- Where
- 5 sites in Belgium, Germany and 1 more
- Volunteers
- 89 people
- Sponsor
- Olympus Europe SE & Co. KG
Endoscopic Retrograde Cholangiopancreatography
Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience
The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.
- Trial name
- NCT04223830
- Testing
- Exalt Model D Single-Use Duodenoscope
- Where
- 7 sites in United States, Netherlands
- Volunteers
- 200 people
- Sponsor
- Boston Scientific Corporation